Previous Article | Next Article 
Antimicrob Agents Chemother. 1987 February; 31(2): 168-172
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.
K L Hartshorn,
M W Vogt,
T C Chou,
R S Blumberg,
R Byington,
R T Schooley and
M S Hirsch
ABSTRACT
Both recombinant alpha A interferon and azidothymidine inhibit the replication of human immunodeficiency virus in peripheral blood mononuclear cells. Combinations of recombinant alpha A interferon and azidothymidine at concentrations that are easily achievable in patients synergistically inhibit human immunodeficiency virus in vitro with minimal toxicity. Combinations of antiretroviral compounds that act by different mechanisms may prove useful in the treatment of acquired immunodeficiency syndrome-related disorders.
Antimicrob Agents Chemother. 1987 February; 31(2): 168-172
This article has been cited by other articles:
-
Chou, T.-C.
(2006). Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol. Rev.
58: 621-681
[Abstract]
[Full Text]
-
Okada, A. A.
(1998). Cytokine Therapy in Eye Disease. Arch Ophthalmol
116: 1514-1516
[Full Text]
-
Saxena, S. K., Gravell, M., Wu, Y.-N., Mikulski, S. M., Shogen, K., Ardelt, W., Youle, R. J.
(1996). Inhibition of HIV-1 Production and Selective Degradation of Viral RNA by an Amphibian Ribonuclease. J. Biol. Chem.
271: 20783-20788
[Abstract]
[Full Text]
-
Fox, N. W., McArthur, C. P.
(1993). Acquired Immunodeficiency Syndrome-- A Review and Update: History, Characteristics of Human Immunodeficiency Virus Infection, Its Replication, Biologic Factors, and Pathogenicity. Arch Fam Med
2: 1068-1077
[Abstract]
-
Hirsch, M. S., D'Aquila, R. T.
(1993). Therapy for Human Immunodeficiency Virus Infection. NEJM
328: 1686-1695
[Full Text]
-
McLeod, G. X., Hammer, S. M.
(1992). Zidovudine: Five Years Later. ANN INTERN MED
117: 487-501
[Abstract]
-
Sachs, M. K.
(1992). Antiretroviral Chemotherapy of Human Immunodeficiency Virus Infections Other Than With Azidothymidine. Arch Intern Med
152: 485-501
[Abstract]
-
Mitsuya, H, Yarchoan, R, Broder, S
(1990). Molecular targets for AIDS therapy. Science
249: 1533-1544
[Abstract]
-
Krown, S. E., Gold, J. W.M., Niedzwiecki, D., Bundow, D., Flomenberg, N., Gansbacher, B., Brew, B. J.
(1990). Interferon-{alpha} with Zidovudine: Safety, Tolerance, and Clinical and Virologic Effects in Patients with Kaposi Sarcoma Associated with the Acquired Immunodeficiency Syndrome (AIDS). ANN INTERN MED
112: 812-821
[Abstract]
-
Kovacs, J. A., Deyton, L., Davey, R., Falloon, J., Zunich, K., Lee, D., Metcalf, J. A., Bigley, J. W., Sawyer, L. A., Zoon, K. C., Masur, H., Fauci, A. S., Clifford Lane, H.
(1989). Combined Zidovudine and Interferon-{alpha} Therapy in Patients with Kaposi Sarcoma and the Acquired Immunodeficiency Syndrome (AIDS). ANN INTERN MED
111: 280-287
[Abstract]
-
Groopman, J. E., Scadden, D. T.
(1989). Interferon Therapy for Kaposi Sarcoma Associated with the Acquired Immunodeficiency Syndrome (AIDS). ANN INTERN MED
110: 335-337
[Abstract]
-
(1988). Kaposi's Sarcoma Responsive to Interferon Therapy. Arch Dermatol
124: 21-22
[Abstract]
-
Vogt, M., Hartshorn, K., Furman, P., Chou, T., Fyfe, J., Coleman, L., Crumpacker, C, Schooley, R., Hirsch, M.
(1987). Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science
235: 1376-1379
[Abstract]